This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (1162)
-
July 17, 2025 | Official Statement US judge denies GTCR motion to compel FDA data on medical devices using lubricious coatings
Sections: DealRisk® and Mergers and Acquisitions
-
July 16, 2025 | Insight American Regent secures rare relief in US generic drug dispute over selenious acid
...., Cipla, RK Pharma and Sun.The New York-based plaintiff in April 2019 secured from the US Food and Drug...
Sections: Intellectual Property
-
July 09, 2025 | Official Statement Merck to buy Verona Pharma for $10 billion
...Food and Drug Administration approved Ohtuvayre in June 2024 for the maintenance treatment of chronic...
Sections: DealRisk® and Mergers and Acquisitions
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login